| PNI present (n = 63) | PNI absent (n = 61) | Univariate | Multivariate | |
---|---|---|---|---|---|
P value | P value | Adjusted odds ratio (95% CI) | |||
Mean age [years] | 63.7 ± 5.0 | 64.0 ± 5.0 | 0.894 |  |  |
PSA [ng/ml] | 9.5 ± 5.9 | 8.5 ± 8.5 | 0.104 |  |  |
Gleason score at biopsy | 7.4 ± 1.1 | 6.7 ± 0.9 | <0.001 | 0.001 | 1.983 (1.342-2.929) |
cT stage (n) | Â | Â | 0.615 | Â | Â |
T1c | 49 (77.8%) | 50 (82.0%) | Â | Â | Â |
T2 | 9 (14.3%) | 9 (14.8%) | Â | Â | Â |
T3a | 5 (7.9%) | 2 (3.3%) | Â | Â | Â |
%positive cores | 23.5 ± 18.7 | 19.8 ±14.8 | 0.513 |  |  |
TZ biopsy positive (n) | 24 (38.1%) | 18 (29.5%) | 0.312 | Â | Â |
Number of apex-positive (2–4/0–1) (n) | 14/49 | 15/46 | 0.755 |  |  |
Number of middle-positive (2–4/0–1) (n) | 21/42 | 13/48 | 0.134 |  |  |
Number of base-positive (2–4/0–1) (n) | 17/46 | 10/51 | 0.153 |  |  |